Back to results
US 2022/0089709 A1Published application
Protein binding to fibronectin b domain
AssigneeHefei Lifeon Pharmaceutical Co., Ltd.
InventorsMei Zhang, Junqiu Ji, Meihua Gao, Jun Chen
Life of this patent
Estimating the term…
Abstract
The present invention relates to an epitope on fibronectin B (ED-B) domain, more specifically to an antibody or an antibody fragment of ED-B domain, and can be widely applied in in-vitro detection and in-vivo positioning of ED-B domain as well as in targeted cancer therapy.
Claims20
An isolated antibody or antigen-binding fragment thereof that specifically binds to a peptide comprising the amino acid sequence selected from the group consisting of VDITDS (SEQ ID NO:
- 76), TGLEPGIDY (SEQ ID NO:
- 88), and NSSTIIGYR (SEQ ID NO:
- 81).
Dependencies are inferred from the claim text.